Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. TDOC
  6. >
  7. Earnings
stocks logo

TDOC Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of Teladoc Health Inc(TDOC) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Teladoc Health Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
-2025-10-29After Hours-0.26-0.21+19.23625.20M626.44M+0.20+6.20-3.04
FY2025Q22025-07-29After Hours-0.27-0.19+29.63622.40M631.90M+1.53-1.73-7.44
FY2025Q12025-04-30After Hours-0.33-0.19+42.42619.23M629.37M+1.64-2.78-5.70
FY2024Q42025-02-26After Hours-0.21-0.28-33.33639.44M640.49M+0.16-13.56-17.83
FY2024Q32024-10-30After Hours-0.29-0.19+34.48631.94M640.51M+1.36+1.58+6.55
FY2024Q22024-07-31--0.36-0.28+22.22649.66M642.44M-1.11-3.08-23.02
FY2024Q12024-04-25--0.47-0.49-4.26637.42M646.13M+1.37-2.91-6.70
FY2023Q42024-02-20--0.22-0.17+22.73671.09M660.53M-1.57-2.57-29.67
FY2023Q32023-10-24--0.37-0.35+5.41663.06M660.24M-0.43+0.61-10.33
FY2023Q22023-07-25--0.44-0.40+9.09649.18M652.41M+0.50-2.52+27.39
AI Stock Picker
AI Stock Picker

TDOC Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Teladoc Health Inc reported performance for , announced on 2025-10-29. The company achieved an EPS of -0.21, compared to analyst estimates of -0.26 by 19.23% . Revenue for the quarter reached 626.44M compared to expectations of 625.20M by 0.20% .
The stock price reacted with a 6.20% one-day change and a -3.04% five-day change following the earnings release. These movements reflect market reaction in Teladoc Health Inc growth trajectory and strategic initiatives.

TDOC Earnings Forecast

Looking ahead, Teladoc Health Inc(TDOC) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 635.06M and an EPS of -0.21.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.07%, while EPS estimates have been Revise Downward by -17.51%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 0.12% . These revisions correlate with a -0.51% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Teladoc Health Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between TDOC's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.07%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-17.51%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Upward
up Image
+0.12%
In Past 3 Month
Stock Price
Go Down
down Image
-0.51%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:2.52B
--
EPS Estimate-Annual FY 2025:-0.99
—
Stock Price7.78
Financial AI Agent
Financial AI Agent

TDOC Revenue and EPS Performance: A Historical Perspective

Teladoc Health Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(2025-10-29,After Hours):
EPS: -0.21 (Actual) vs.-0.26 (Estimate) (19.23%)
Revenue: 626.44M (Actual) vs. 625.20M (Estimate) (0.20%)
Price Reaction: 6.20%(1-Day), -3.04%(5-Day)
FY2025Q2 (2025-07-29,After Hours):
EPS: -0.19 (Actual) vs.-0.27 (Estimate) (29.63%)
Revenue: 631.90M (Actual) vs. 622.40M (Estimate) (1.53%)
Price Reaction: -1.73%(1-Day), -7.44%(5-Day)
FY2025Q1 (2025-04-30,After Hours):
EPS: -0.19 (Actual) vs.-0.33 (Estimate) (42.42%)
Revenue: 629.37M (Actual) vs. 619.23M (Estimate) (1.64%)
Price Reaction: -2.78%(1-Day), -5.70%(5-Day)
Earnings Reaction
The chart below shows how TDOC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, TDOC sees a +6.66% change in stock price 10 days leading up to the earnings, and a -8.56% change 10 days following the report. On the earnings day itself, the stock moves by -2.45%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 6.20% on the day following the earnings release and then changed by -9.23% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Intellectia AI SwingMax
Intellectia AI SwingMax

Transcript Summary

Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Summary
Positive
2025-10-29
The earnings call summary shows strong financial metrics with optimistic guidance, particularly in Integrated Care revenue growth. While BetterHelp faces a revenue decline, new initiatives like insurance could offset this. The Q&A session indicates positive analyst sentiment, with management addressing concerns about customer acquisition and integration strategies. Announcements of strategic priorities and operational excellence further bolster confidence. Given the market cap, the stock is likely to see a positive movement of 2% to 8%.
Teladoc Health Inc (TDOC) Q2 2025 Earnings Call Summary
Neutral
2025-07-29
The earnings call presents a mixed picture: while there are headwinds in the BetterHelp segment and uncertainty in margins, there are positive developments such as international growth and strategic partnerships. The Q&A section reveals analysts' concerns about competitive pressures and unclear management responses, particularly in the insurance rollout and growth trajectory. The overall sentiment is balanced by strategic initiatives and the potential for future growth, leading to a neutral stock price prediction.
Teladoc Health Inc (TDOC) Q1 2025 Earnings Call Summary
Neutral
2025-04-30
The earnings call presents mixed signals: while there are positive aspects like strong international revenue growth and improved free cash flow, challenges such as revenue declines in the BetterHelp segment and increased churn due to shorter-duration contracts are concerning. Additionally, the lack of clear guidance on securing payer coverage and the expected headwinds from the UpLift acquisition and tariffs add uncertainty. Given the market cap of $1.7 billion, the stock price is likely to remain stable, resulting in a neutral rating with minor fluctuations.
Teladoc Health Inc (TDOC) Q1 2025 Earnings Call Summary
Neutral
2025-04-30
The earnings call presents mixed signals: while revenue and EBITDA are at the high end of guidance, net losses increased and BetterHelp's revenue declined. The Q&A reveals concerns about high churn rates and unclear management responses regarding BetterHelp's payer coverage and Uplift integration. Despite positive growth in Integrated Care membership and stable CAC trends, the lack of clarity and lower BetterHelp margins balance out the positive aspects. Given the mid-sized market cap, the stock is likely to remain stable, with a neutral prediction of -2% to 2% movement.
Teladoc Health Inc (TDOC) Q4 2024 Earnings Call Summary
Neutral
2025-02-26
The earnings call reveals a mixed picture: Integrated Care shows modest revenue growth and expansion, but BetterHelp faces challenges and declining revenue. Financial metrics are stable but uninspiring, with a net loss and no significant year-over-year improvement. The Q&A highlights stable utilization trends and a shift towards visit fee arrangements, but management's vague responses on client transitions and health plan challenges limit positive sentiment. The potential share buyback is a positive factor, but overall, the mixed results and cautious guidance suggest a neutral stock price movement, especially given the company's small-cap status.
Teladoc Health, Inc. (TDOC) Q3 2024 Earnings Call Summary
Negative
2024-10-31
The earnings call summary presents several challenges: declining revenue in key segments, high customer acquisition costs, and uncertainties in guidance. The Q&A reveals unclear management responses, especially regarding future investments and costs, adding to the uncertainty. Despite a strong cash position and some positive growth metrics, the withdrawal of long-term guidance and operational challenges weigh heavily. Given the company's small market cap, the stock is likely to react negatively, with a potential decline of 2% to 8% over the next two weeks.
Teladoc Health, Inc. (TDOC) Q2 2024 Earnings Call Summary
Negative
2024-08-01
The earnings call highlights several concerns: elevated customer acquisition costs, a goodwill impairment charge, and competitive pressures affecting BetterHelp. The withdrawal of BetterHelp's guidance indicates significant uncertainty. Despite some positive aspects, such as cost-saving initiatives and cash reserves, the overall sentiment is negative due to operational challenges and a significant net loss per share. The stock's small market cap suggests a more volatile reaction, likely resulting in a negative stock price movement between -2% and -8% over the next two weeks.

People Also Watch

FAQ

arrow icon

What were the key highlights of TDOC’s latest earnings report for ?

TDOC reported its earnings on 2025-10-29, showcasing a revenue of 626.44M against an estimate of 625.20M, resulting in a 0.2% surprise. The EPS was -0.21, surpassing the expected -0.26 by 19.23% . The stock experienced a 6.2% price change on the earnings day and a -3.04% change over the next five days, reflecting market reactions to the results.
arrow icon

How did TDOC’s stock price react after the earnings release?

Following TDOC’s earnings announcement on 2025-10-29, the stock price moved by 6.20% on the day of the release. Over the subsequent five days, it saw a -3.04% change. Historically, TDOC’s stock price tends to shift by an average of +6.66% in the 10 days leading up to earnings and -8.56% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for TDOC for 2025/Q4?

For 2025/Q4, analysts estimate TDOC’s annual revenue to reach 635.06M, while the EPS is projected at -0.21. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.07% and EPS estimates Revise Upward by 0.12% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does TDOC’s stock price correlate with earnings forecast revisions?

The correlation between TDOC’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.07%, while EPS estimates moved Revise Upward by 0.12% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from TDOC’s next earnings report?

Based on historical trends, TDOC’s stock price typically moves by +6.66% in the 10 days before its earnings and -8.56% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.21 and revenue of 635.06M.
arrow icon

What is the sentiment in Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Summary?

The earnings call summary shows strong financial metrics with optimistic guidance, particularly in Integrated Care revenue growth. While BetterHelp faces a revenue decline, new initiatives like insurance could offset this. The Q&A session indicates positive analyst sentiment, with management addressing concerns about customer acquisition and integration strategies. Announcements of strategic priorities and operational excellence further bolster confidence. Given the market cap, the stock is likely to see a positive movement of 2% to 8%.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free